{"id":"anti-hypertensive-drugs","safety":{"commonSideEffects":[{"rate":null,"effect":"Dizziness or lightheadedness"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Cough (ACE inhibitor-specific)"},{"rate":null,"effect":"Hyperkalemia (ACE inhibitor/ARB-specific)"},{"rate":null,"effect":"Hypotension"}]},"_chembl":{"chemblId":"CHEMBL2108941","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Anti-hypertensive drugs represent a broad class of medications that reduce blood pressure through multiple distinct mechanisms. Common approaches include blocking angiotensin II (ACE inhibitors, ARBs), inhibiting sympathetic nervous system activity (beta-blockers, alpha-blockers), promoting vasodilation (calcium channel blockers, nitrates), or increasing sodium and water excretion (diuretics). The specific mechanism depends on the drug subclass within this category.","oneSentence":"Anti-hypertensive drugs lower blood pressure through various mechanisms including vasodilation, reduced cardiac output, or decreased peripheral vascular resistance.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:01:52.784Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension (essential or secondary)"},{"name":"Blood pressure reduction in cardiovascular disease prevention"}]},"trialDetails":[{"nctId":"NCT06709352","phase":"","title":"Effect of Hypertensive Drugs on Root Caries Among Senior Patients in Cairo University","status":"COMPLETED","sponsor":"Cairo University","startDate":"2025-02-01","conditions":"Root Caries, Antihypertensive Drugs","enrollment":209},{"nctId":"NCT05163158","phase":"NA","title":"CENtral Blood Pressure Targeting: A Pragmatic RAndomized Pilot triaL in Advanced Chronic Kidney Disease","status":"COMPLETED","sponsor":"Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal","startDate":"2022-05-24","conditions":"Chronic Kidney Diseases, Hypertension","enrollment":116},{"nctId":"NCT06108427","phase":"NA","title":"REnin-guided TherApy With MinEralocorticoid Receptor Antagonists in Primary Aldosteronism - Feasibility Study","status":"RECRUITING","sponsor":"Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal","startDate":"2024-04-25","conditions":"Primary Aldosteronism","enrollment":58},{"nctId":"NCT04789733","phase":"NA","title":"The GUARDIAN Pilot Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2021-04-27","conditions":"General Surgery","enrollment":80},{"nctId":"NCT07475949","phase":"PHASE3","title":"Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Guangxi Medical University","startDate":"2026-04","conditions":"Acute Ischemic Stroke, Tenecteplase","enrollment":352},{"nctId":"NCT07475936","phase":"","title":"Intravenous Tenecteplase in Very Old Patients With Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Guangxi Medical University","startDate":"2026-04","conditions":"Acute Ischemic Stroke, Tenecteplase","enrollment":392},{"nctId":"NCT06649370","phase":"","title":"Effect of Systemic Inflammatory Index and Systemic Immune Inflammation Index on Ecchymosis, Bleeding and Edema","status":"COMPLETED","sponsor":"Tokat Gaziosmanpasa University","startDate":"2024-06-01","conditions":"Rhinoplasty","enrollment":94},{"nctId":"NCT07458880","phase":"NA","title":"Triple Antihypertensive Medication After Intracerebral Hemorrhage for Blood Pressure Control","status":"RECRUITING","sponsor":"The University of Hong Kong","startDate":"2026-03-01","conditions":"Intracerebral Hemorrhage","enrollment":140},{"nctId":"NCT04412096","phase":"PHASE4","title":"Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2020-11-23","conditions":"Glaucoma, OHT - Ocular Hypertension","enrollment":59},{"nctId":"NCT06907147","phase":"NA","title":"SPYRAL GEMINI Pilot Study","status":"RECRUITING","sponsor":"Medtronic Vascular","startDate":"2025-05-01","conditions":"Hypertension, Vascular Diseases, Cardiovascular Diseases","enrollment":175},{"nctId":"NCT07166991","phase":"PHASE3","title":"Anesthesia sTrategy foR Organ Procurement In braiN dEath","status":"RECRUITING","sponsor":"University Hospital, Grenoble","startDate":"2026-02-17","conditions":"Brain-dead Organ Donors","enrollment":270},{"nctId":"NCT05894954","phase":"PHASE3","title":"Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment","status":"COMPLETED","sponsor":"Alzheimer's Prevention and Reversal Project, Inc.","startDate":"2023-07-31","conditions":"Mild Cognitive Impairment, Dementia, Mild","enrollment":73},{"nctId":"NCT07099677","phase":"NA","title":"Short-Term Effects of Antihypertensive Drugs on Postural Balance and Fall Risk","status":"RECRUITING","sponsor":"Abant Izzet Baysal University","startDate":"2025-08-01","conditions":"Hypertension, Fall Risk, Postural Balance","enrollment":186},{"nctId":"NCT07061054","phase":"NA","title":"Netrod-Pilot Study of Renal Denervation With NetrodTM Sixelectrode Radiofrequency RDN System","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Golden Leaf MedTec Co. Ltd","startDate":"2026-04-01","conditions":"Uncontrolled Hypertension","enrollment":20},{"nctId":"NCT07397481","phase":"PHASE4","title":"Clinical Application of Simcyp-Guided Doses of Antihypertensive Drugs in Cirrhotic Patients","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2024-03-01","conditions":"Liver Cirrhosis, Arterial Hypertension","enrollment":40},{"nctId":"NCT05760898","phase":"NA","title":"Improving Hypertension Control in Rheumatoid Arthritis","status":"RECRUITING","sponsor":"Duke University","startDate":"2026-01-16","conditions":"Hypertension, Rheumatoid Arthritis","enrollment":25},{"nctId":"NCT05780710","phase":"NA","title":"OBPM_Meds2023: Multicentric Prospective Clinical Study to Evaluate the Aktiia Optical Blood Pressure Monitoring (OBPM) Device Compared to Standard Home Blood Pressure Monitoring (HBPM) in Hypertensive Patients When Blood Pressure Lowering Medications Intake","status":"RECRUITING","sponsor":"Aktiia SA","startDate":"2023-06-29","conditions":"Hypertension","enrollment":35},{"nctId":"NCT07364175","phase":"NA","title":"A Trial Within Cohort Feasibility Study Design Comparing Standard of Care Versus Weight Loss (Achieved Through Tirzepatide) for Obesity-related Hypertension in Young Adults","status":"RECRUITING","sponsor":"Cambridge University Hospitals NHS Foundation Trust","startDate":"2026-01","conditions":"Hypertension, Obesity & Overweight","enrollment":60},{"nctId":"NCT07362966","phase":"PHASE4","title":"Effect of Colchicine on Progression of Coronary Atherosclerosis in Patients With TET2-CHIP Variant","status":"NOT_YET_RECRUITING","sponsor":"Shenyang Northern Hospital","startDate":"2026-02-24","conditions":"Colchicine, Coronary Atherosclerosis Management, Clonal Hematopoiesis of Indeterminate Potential","enrollment":120},{"nctId":"NCT07002476","phase":"PHASE3","title":"Early Aggressive Strategy for Treatment of Lipid-Lowering in Acute Ischemic Stroke Delivered With Endovascular Therapy for Large Artery Occlusion","status":"RECRUITING","sponsor":"Shanghai East Hospital","startDate":"2025-06-19","conditions":"Stroke","enrollment":652},{"nctId":"NCT05609513","phase":"NA","title":"Integration of Hypertension Management in HIV Care in Uganda","status":"COMPLETED","sponsor":"Infectious Diseases Research Collaboration, Uganda","startDate":"2023-02-06","conditions":"HIV/AIDS, Hypertension","enrollment":87421},{"nctId":"NCT05370599","phase":"PHASE2","title":"Hypertension in Young Adults Trial","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2022-04-15","conditions":"Hypertension","enrollment":36},{"nctId":"NCT06069102","phase":"PHASE4","title":"Optimal Blood Pressure Treatment Thresholds Postpartum","status":"COMPLETED","sponsor":"Alisse Hauspurg","startDate":"2023-11-15","conditions":"Hypertensive Disorder of Pregnancy, Pre-Eclampsia, Hypertension","enrollment":61},{"nctId":"NCT05830305","phase":"NA","title":"MOBILE Health Intervention in IntraCerebral Hemorrhage Survivors","status":"RECRUITING","sponsor":"The University of Hong Kong","startDate":"2023-10-01","conditions":"Intracerebral Hemorrhage, Hypertension","enrollment":140},{"nctId":"NCT06994975","phase":"PHASE3","title":"CHinese ischEmic Stroke Beyond 4.5 Hours With TeNecteplase Under Optimized Non-Contrast CT Selection","status":"RECRUITING","sponsor":"Huashan Hospital","startDate":"2025-11-03","conditions":"Acute Ischemic Stroke","enrollment":890},{"nctId":"NCT03924531","phase":"NA","title":"Promoting Adherence to Anti-Hypertensive Medications and Lifestyle Guidelines Through Mindfulness Practice","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2017-08-01","conditions":"Health Behavior Modification Using Mindfulness","enrollment":36},{"nctId":"NCT06618521","phase":"NA","title":"Effect of Pilates Exercise Versus Circuit Exercise Training on Gestational Hypertension","status":"COMPLETED","sponsor":"Cairo University","startDate":"2024-09-30","conditions":"Gestational Hypertension","enrollment":69},{"nctId":"NCT02770066","phase":"","title":"A Prospective Danish National Registry of PTRA in Patients With Renovascular Hypertension","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2015-01-01","conditions":"Renal Artery Obstruction, Hypertension, Renovascular, Cardiovascular Diseases","enrollment":160},{"nctId":"NCT07273877","phase":"","title":"A Real-World Study on the Treatment of Hypertension With Netrod-RDN Renal Artery Radiofrequency Ablation System","status":"ENROLLING_BY_INVITATION","sponsor":"Shanghai Golden Leaf MedTec Co. Ltd","startDate":"2025-08-07","conditions":"Hypertension","enrollment":1000},{"nctId":"NCT07269288","phase":"","title":"The Correlation and Mechanistic Study of GGCX Gene With Prognosis in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Peking University Aerospace Center Hospital","startDate":"2026-01-25","conditions":"Acute Ischemic Stroke","enrollment":1500},{"nctId":"NCT05963568","phase":"PHASE3","title":"Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment II Study (SMAART II)","status":"NOT_YET_RECRUITING","sponsor":"Northern California Institute of Research and Education","startDate":"2026-01-01","conditions":"Stroke, Medication Adherence","enrollment":680},{"nctId":"NCT07261098","phase":"PHASE2","title":"The Efficacy and Safety of ARNI on the Outcome of Advanced Lung Cancer With Concurrent Hypertension","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Chest Hospital","startDate":"2026-01-01","conditions":"Advanced Lung Cancer","enrollment":200},{"nctId":"NCT07255677","phase":"NA","title":"Effect of Stretching Exercises Versus Aerobic Exercises on Preeclampsia","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2025-11-30","conditions":"Preeclampsia","enrollment":60},{"nctId":"NCT07240909","phase":"PHASE4","title":"Antihypertensive Drug Selection Based on Hemodynamic Phenotypes","status":"NOT_YET_RECRUITING","sponsor":"The Third Xiangya Hospital of Central South University","startDate":"2026-01","conditions":"Hypertension","enrollment":240},{"nctId":"NCT07222852","phase":"PHASE3","title":"Cardiovascular Protection After Preeclampsia With Enalapril","status":"NOT_YET_RECRUITING","sponsor":"Women and Infants Hospital of Rhode Island","startDate":"2025-11-15","conditions":"Preeclampsia, Hypertensive Disorder of Pregnancy, Hypertension","enrollment":60},{"nctId":"NCT05459077","phase":"NA","title":"Addressing Barriers to Anti-hypertensive Medication Adherence Among PLWH Who Have Achieved Viral Suppression","status":"NOT_YET_RECRUITING","sponsor":"Duke University","startDate":"2025-11-20","conditions":"Hypertension, HIV-1-infection","enrollment":60},{"nctId":"NCT05585125","phase":"PHASE4","title":"A Preliminary Study for INFORMED","status":"ENROLLING_BY_INVITATION","sponsor":"Weill Medical College of Cornell University","startDate":"2024-02-07","conditions":"Heart Failure, Heart Failure, Diastolic, Heart Failure With Preserved Ejection Fraction","enrollment":20},{"nctId":"NCT05159999","phase":"NA","title":"The Home Blood Pressure (BP) Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Washington","startDate":"2022-02-02","conditions":"End Stage Renal Disease on Dialysis","enrollment":200},{"nctId":"NCT07207226","phase":"NA","title":"Arterial Stiffness as a Tool to Investigate Adherence in Resistant Hypertension","status":"RECRUITING","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2024-11-27","conditions":"Resistant Hypertension","enrollment":60},{"nctId":"NCT07188272","phase":"NA","title":"Effect of High-intensity Interval Training Combined With DASH Diet on Arterial Stiffness in Hypertensive Patients","status":"RECRUITING","sponsor":"Deraya University","startDate":"2025-07-10","conditions":"Hypertension, Arterial Stiffness","enrollment":20},{"nctId":"NCT04753840","phase":"NA","title":"Long-term of Remote Ischemic Preconditioning in Patients With Mild Hypertension","status":"RECRUITING","sponsor":"Henan Institute of Cardiovascular Epidemiology","startDate":"2021-07-03","conditions":"Hypertension","enrollment":90},{"nctId":"NCT02472028","phase":"PHASE4","title":"Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-09","conditions":"Cerebrovascular Disorders","enrollment":820},{"nctId":"NCT07149922","phase":"NA","title":"Early Blood Pressure Intervention After Coiling or Clipping for Subarachnoid Hemorrhage","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-08-31","conditions":"Aneurysmal Subarachnoid Hemorrhage, Aneurysmal Subarachnoid Hemorrhage (aSAH)","enrollment":750},{"nctId":"NCT07137364","phase":"","title":"Efficacy of Spironolactone Combined With Antihypertensive Drugs in Patients With Primary Aldosteronism","status":"RECRUITING","sponsor":"Third Military Medical University","startDate":"2022-05-01","conditions":"Primary Aldosteronism, Hypertension","enrollment":350},{"nctId":"NCT06796660","phase":"EARLY_PHASE1","title":"Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients","status":"NOT_YET_RECRUITING","sponsor":"Liu Zhanghong","startDate":"2025-09-01","conditions":"Renal Insufficiency, Chronic","enrollment":70},{"nctId":"NCT02188381","phase":"","title":"The Role of Gut Microbiota in Hypertension","status":"COMPLETED","sponsor":"University of Florida","startDate":"2014-07","conditions":"Hypertension","enrollment":292},{"nctId":"NCT04991961","phase":"","title":"Effect of Anti-hypertensive Medications on the Diagnostic Accuracy in Primary Aldosteronism","status":"COMPLETED","sponsor":"Chongqing Medical University","startDate":"2020-09-15","conditions":"Hypertension, Primary Aldosteronism","enrollment":341},{"nctId":"NCT06090890","phase":"PHASE4","title":"Anti-inflammatory Therapy for Recurrent In-stent Restenosis","status":"RECRUITING","sponsor":"Fu Wai Hospital, Beijing, China","startDate":"2023-10-30","conditions":"In-stent Restenosis","enrollment":252},{"nctId":"NCT05331144","phase":"PHASE2","title":"Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)","status":"RECRUITING","sponsor":"Rong Zhang","startDate":"2022-10-25","conditions":"Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline","enrollment":180},{"nctId":"NCT05920005","phase":"PHASE3","title":"Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT®️ for Systemic Arterial Hypertension","status":"COMPLETED","sponsor":"Hospital Israelita Albert Einstein","startDate":"2023-08-22","conditions":"Hypertension","enrollment":702},{"nctId":"NCT07047547","phase":"NA","title":"A Study of Real-world Events of Vericiguat in Patients With Chronic Kidney Disease and Heart Failure","status":"RECRUITING","sponsor":"Guangdong Provincial People's Hospital","startDate":"2025-06-01","conditions":"Hemodialysis Complication, Heart Failure","enrollment":118},{"nctId":"NCT06859359","phase":"NA","title":"Improving Maternal Cardiovascular Outcomes Through the Implementation of a Hypertensive Disorders of Pregnancy Bundle in Nigeria","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2025-06-02","conditions":"Hypertensive Disorder of Pregnancy","enrollment":1200},{"nctId":"NCT03354143","phase":"PHASE2","title":"Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2018-04-10","conditions":"Hypertension","enrollment":85},{"nctId":"NCT07032116","phase":"","title":"YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study1","status":"NOT_YET_RECRUITING","sponsor":"Liu Hongfang","startDate":"2025-08-01","conditions":"Diabetic Kidney Disease (DKD)","enrollment":4472},{"nctId":"NCT05353335","phase":"NA","title":"Chronotherapy in Children With Chronic Kidney Disease","status":"WITHDRAWN","sponsor":"Yale University","startDate":"2025-04","conditions":"Chronic Kidney Diseases, Hypertension","enrollment":""},{"nctId":"NCT07020104","phase":"NA","title":"The Role of Skin Sodium Accumulation in Chronic Kidney Disease","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2025-01-07","conditions":"Chronic Kidney Diseases","enrollment":60},{"nctId":"NCT07017296","phase":"NA","title":"Microencapsulated Pomegranate Juice as Anti-Hypertensive","status":"COMPLETED","sponsor":"Universidad Autónoma del Estado de Hidalgo","startDate":"2024-08-15","conditions":"Clinical Trial","enrollment":20},{"nctId":"NCT04464746","phase":"NA","title":"Therapeutic Adherence in Uncontrolled Arterial Hypertension","status":"COMPLETED","sponsor":"Parc de Salut Mar","startDate":"2018-07-01","conditions":"Treatment Adherence","enrollment":47},{"nctId":"NCT04899206","phase":"","title":"ANGIOTENSIN AGENTS AND REDUCTION OF THE PRESCRIPTION OF ANTIDEPRESSANT DRUGS: A RETROSPECTIVE COHORT STUDY USING REAL-WORLD DATA","status":"WITHDRAWN","sponsor":"Sebastian Videla","startDate":"2021-04-12","conditions":"ACE Inhibitors, ARB, Hypertension","enrollment":""},{"nctId":"NCT06964217","phase":"","title":"Immediate Fracture Risk After Antihypertensive Drug Initiation","status":"NOT_YET_RECRUITING","sponsor":"Ajou University School of Medicine","startDate":"2025-06-01","conditions":"Hypertension, Fracture","enrollment":10000000},{"nctId":"NCT03396588","phase":"PHASE3","title":"Non-Opiate Treatment After Prenatal Opiate Exposure to Prevent Postnatal Injury to the Young Brain","status":"COMPLETED","sponsor":"Henrietta Bada","startDate":"2017-12-07","conditions":"Neonatal Abstinence Syndrome","enrollment":120},{"nctId":"NCT06823570","phase":"NA","title":"Anti-hypertensive Therapy and Exercise Treatment to Improve Vascular Health in Patients With Hypertension.","status":"RECRUITING","sponsor":"Heinrich-Heine University, Duesseldorf","startDate":"2025-04-01","conditions":"Hypertension, Vascular Function, Fitness Testing","enrollment":60},{"nctId":"NCT04637152","phase":"PHASE2","title":"Sacubitril/Valsartan in Resistant Hypertension","status":"COMPLETED","sponsor":"Hospital Geral Roberto Santos","startDate":"2020-11-11","conditions":"Resistant Hypertension, Blood Pressure","enrollment":80},{"nctId":"NCT03505723","phase":"PHASE3","title":"PeriOperative ISchemic Evaluation-3 Trial","status":"COMPLETED","sponsor":"Population Health Research Institute","startDate":"2018-06-27","conditions":"Perioperative Bleeding, Venous Thrombosis, Arterial Thrombosis","enrollment":9535},{"nctId":"NCT05963880","phase":"NA","title":"Concordance Between Central Blood PRessure dEvices In Nephrology Patients","status":"TERMINATED","sponsor":"Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal","startDate":"2021-04-26","conditions":"Hypertension, Chronic Kidney Disease, Blood Pressure","enrollment":119},{"nctId":"NCT04893733","phase":"PHASE4","title":"Intravenous Administration of Vitamin B Complex Improves Renal Recovery in Patients With AKI","status":"COMPLETED","sponsor":"Caja Nacional de Salud","startDate":"2020-09-01","conditions":"Acute Kidney Injury","enrollment":260},{"nctId":"NCT06284213","phase":"","title":"Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2021-09-29","conditions":"Cognitive Impairment, Dementia","enrollment":1892},{"nctId":"NCT06780865","phase":"NA","title":"Protecting Renal Function in Chronic Kidney Disease Patients with Isolated Nighttime Hypertension","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Institute of Hypertension","startDate":"2025-01-30","conditions":"Chronic Kidney Disease(CKD), Nocturnal Hypertension","enrollment":200},{"nctId":"NCT04035824","phase":"PHASE4","title":"Gastrodia and Uncaria Recipe in Treating Stage-one Hypertension: an Evidence-based Optimization Study","status":"COMPLETED","sponsor":"Shanghai Institute of Hypertension","startDate":"2019-10-08","conditions":"Hypertension","enrollment":605},{"nctId":"NCT05089448","phase":"PHASE4","title":"Morning Versus Bedtime Dosing of Antihypertensive Medication","status":"RECRUITING","sponsor":"Yan Li","startDate":"2021-01-28","conditions":"Hypertension, Blood Pressure, Drug Use","enrollment":300},{"nctId":"NCT05858944","phase":"NA","title":"Home Blood Pressure Intervention in the Community Trial","status":"RECRUITING","sponsor":"Shanghai Institute of Hypertension","startDate":"2023-05-06","conditions":"Home Blood Pressure","enrollment":10000},{"nctId":"NCT04137549","phase":"","title":"Registry Study on \"Control Nocturnal Hypertension to Reach the Target \"","status":"RECRUITING","sponsor":"Shanghai Institute of Hypertension","startDate":"2019-12-01","conditions":"Nocturnal Hypertension","enrollment":4500},{"nctId":"NCT02893358","phase":"PHASE4","title":"Antihypertensive Treatment in Masked Hypertension","status":"COMPLETED","sponsor":"Yan Li","startDate":"2017-02-14","conditions":"Masked Hypertension","enrollment":320},{"nctId":"NCT06755801","phase":"PHASE3","title":"Nebivolol ANOCA Treatment Randomized Trial","status":"NOT_YET_RECRUITING","sponsor":"Spanish Society of Cardiology","startDate":"2025-04-01","conditions":"ANOCA - Angina With Non-obstructive Coronary Arteries, Coronary Microvascular Dysfunction (CMD)","enrollment":150},{"nctId":"NCT06711432","phase":"NA","title":"Different Intraoperative Blood Pressure Management on Postoperative Cognitive Function in Tumor Patients（PRECISION）","status":"RECRUITING","sponsor":"Zhejiang Cancer Hospital","startDate":"2024-09-18","conditions":"Tumor, Stroke","enrollment":214},{"nctId":"NCT06704815","phase":"","title":"Observational Cohort Study Evaluating the Effectiveness of an Educational Program (NGAYDAUTIEN) in Combination With Perindopril and Amlodipine Single-Pill Combination in Hypertensive Patients naïve of Antihypertensive Treatments.","status":"COMPLETED","sponsor":"Servier Affaires Médicales","startDate":"2023-01-31","conditions":"Hypertension","enrollment":400},{"nctId":"NCT05590871","phase":"NA","title":"FlashPoint Renal Denervation Under Columbus 3D Mapping System Guidance for Treating Hypertension","status":"RECRUITING","sponsor":"Shanghai Hongdian Medical CO., LTD","startDate":"2023-03-31","conditions":"Hypertension","enrollment":180},{"nctId":"NCT06683430","phase":"NA","title":"High Potassium Diet with Spices and Herbs As Salt Substitute for Lowering Blood Pressure in Older Adults: Study Protocol","status":"COMPLETED","sponsor":"Universitas Airlangga","startDate":"2022-05-11","conditions":"Hypertension, Older Adults Institutionalized in Residential Homes","enrollment":62},{"nctId":"NCT06680986","phase":"","title":"Echocardiographic Analysis by Artificial Intelligence in Hypertension","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2022-06-01","conditions":"Arterial Hypertension","enrollment":200},{"nctId":"NCT03808311","phase":"NA","title":"Blood Pressure Control Target in Diabetes","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2019-02-24","conditions":"Blood Pressure Control Target in Diabetes","enrollment":12821},{"nctId":"NCT05156385","phase":"NA","title":"Sexual Dysfunction in Hypertensive Women","status":"RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2022-06-27","conditions":"Hypertension","enrollment":348},{"nctId":"NCT06626607","phase":"","title":"Different Antihypertensive Drugs on Aortic Diseases","status":"COMPLETED","sponsor":"Eighth Affiliated Hospital, Sun Yat-sen University","startDate":"2017-01-01","conditions":"Aortic Aneurysm, Aortic Dissection","enrollment":704},{"nctId":"NCT06622304","phase":"","title":"Exploring the Effects of Antihypertensive and Lipid-Lowering Drugs on Inflammatory Cytokine Levels","status":"COMPLETED","sponsor":"Guangzhou Institute of Respiratory Disease","startDate":"2024-04-01","conditions":"Hypertension, Dyslipidemias, Inflammatory Response","enrollment":250736},{"nctId":"NCT04334824","phase":"","title":"Hydrochlorothiazide and Risk of Skin Cancer","status":"COMPLETED","sponsor":"Canadian Network for Observational Drug Effect Studies, CNODES","startDate":"2019-05-27","conditions":"Non-melanoma Skin Cancer, Melanoma, Hypertension","enrollment":2953748},{"nctId":"NCT04197700","phase":"NA","title":"The PRESSURE CABG Cardiac Surgery Trial","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2022-11-01","conditions":"Coronary Artery Bypass Grafting, Hypotension","enrollment":600},{"nctId":"NCT06600347","phase":"NA","title":"Effect of DASH Diet and Progressive Muscle Relaxation on Cardiovascular Risks in Postmenopausal Women","status":"RECRUITING","sponsor":"Cairo University","startDate":"2024-06-10","conditions":"Cardiovascular Complication","enrollment":90},{"nctId":"NCT05972785","phase":"","title":"Long-term Use of CCB and Breast Cancer Risk","status":"ACTIVE_NOT_RECRUITING","sponsor":"Curtin University","startDate":"2022-07-01","conditions":"Hypertension,Essential, Breast Cancer","enrollment":68500},{"nctId":"NCT05363059","phase":"","title":"Effect of Bariatric Surgery Versus Medical Therapy on Metabolic Syndrome","status":"RECRUITING","sponsor":"Third Military Medical University","startDate":"2010-05-01","conditions":"Metabolic Syndrome","enrollment":200},{"nctId":"NCT05322967","phase":"NA","title":"Effect of Chronotherapy on Blood Pressure - Time of Intake of Blood Pressure Lowering Drugs","status":"RECRUITING","sponsor":"Vastra Gotaland Region","startDate":"2022-06-25","conditions":"Hypertension, Drug Therapy, Primary Health Care","enrollment":120},{"nctId":"NCT05169411","phase":"","title":"Preserving Kidney Function in Children With Chronic Kidney Disease","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2023-09-22","conditions":"Chronic Kidney Disease Stage 2, Chronic Kidney Disease Stage 3, Pediatric Kidney Disease","enrollment":20240},{"nctId":"NCT00400218","phase":"PHASE3","title":"Evaluate the Safety and Anti-Hypertensive Efficacy of Hyzaar(R) In Patients With Mild To Moderate Essential Hypertension (0954A-323)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-09-01","conditions":"Hypertension","enrollment":62},{"nctId":"NCT06515678","phase":"","title":"Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Groupe Hospitalier Pitie-Salpetriere","startDate":"2024-05-20","conditions":"Ovarian Cancer, Antiangiogenic-Associated Hypertension, Adjuvant Bevacizumab","enrollment":9464},{"nctId":"NCT06517134","phase":"","title":"Prescribing Patterns of Antihypertensive Drugs in Uncomplicated Hypertension","status":"COMPLETED","sponsor":"University Hospital, Caen","startDate":"2019-01-01","conditions":"Hypertension,Essential, Cardiovascular Diseases","enrollment":3325032},{"nctId":"NCT06513650","phase":"","title":"Mechanism-based Therapy of Hypotensive Syncope","status":"RECRUITING","sponsor":"Istituto Auxologico Italiano","startDate":"2024-05-01","conditions":"Syncope, Vasovagal, Neurally-Mediated","enrollment":140},{"nctId":"NCT06510270","phase":"NA","title":"Dapagliflozin in Reducing Epicardial Adipose Tissue in Heart Failure with Preserved Ejection Fraction","status":"NOT_YET_RECRUITING","sponsor":"Aswan University","startDate":"2024-08-01","conditions":"Heart Failure with Preserved Ejection Fraction","enrollment":70},{"nctId":"NCT05479097","phase":"NA","title":"Feasibility Study of a Novel mHealth Application to Enable Community Health Workers to Manage","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2023-02-06","conditions":"Hypertension","enrollment":32},{"nctId":"NCT06500000","phase":"","title":"The Plasma Metabolomics Profiling of Primary Aldosteronism","status":"COMPLETED","sponsor":"Third Military Medical University","startDate":"2022-08-15","conditions":"Primary Aldosteronism, Essential Hypertension, Idiopathic Aldosteronism","enrollment":95},{"nctId":"NCT06441591","phase":"PHASE2, PHASE3","title":"Clinical Outcome of Vinpocetine in Diabetic Nephropathy","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2024-07-10","conditions":"Diabetic Kidney Disease, Diabetic Nephropathies","enrollment":64},{"nctId":"NCT04647292","phase":"PHASE2","title":"European Blood Pressure Intensive Control After Stroke","status":"RECRUITING","sponsor":"University College Dublin","startDate":"2024-05-02","conditions":"Ischemic Stroke, Transient Ischemic Attack","enrollment":142},{"nctId":"NCT04788563","phase":"NA","title":"A Randomized Patient Preference Trial on Heat-sensitive Moxibustion for Primary Hypertension in Community","status":"COMPLETED","sponsor":"Jiangxi University of Traditional Chinese Medicine","startDate":"2021-03-10","conditions":"Primary Hypertension","enrollment":400}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":967,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Anti-hypertensive drugs","genericName":"Anti-hypertensive drugs","companyName":"Universal Research Group","companyId":"universal-research-group","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Anti-hypertensive drugs lower blood pressure through various mechanisms including vasodilation, reduced cardiac output, or decreased peripheral vascular resistance. Used for Hypertension (essential or secondary), Blood pressure reduction in cardiovascular disease prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}